Publication
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status
Giuseppe Bronte, Tindara Franchina, Massimiliano Alù, Giovanni Sortino, Claudia Celesia, Francesco Passiglia, Giuseppina Savio, Agata Laudani, Alessandro Russo, Antonio Picone, Sergio Rizzo, Michele De Tursi, Elisabetta Gambale, Viviana Bazan, Clara Natoli, Livio Blasi, Vincenzo Adamo, Antonio Russo
Oncotarget, June 2016, Impact Journals, LLC
DOI: 10.18632/oncotarget.8130